J Korean Acad Psychiatr Ment Health Nurs.  2018 Mar;27(1):28-39. 10.12934/jkpmhn.2018.27.1.28.

An Integrative Literature Review of Quality of Life Intervention Programs for Patients with Schizophrenia

• Kim GU
• Jung EY

• KMID: 2408061
• DOI: http://doi.org/10.12934/jkpmhn.2018.27.1.28

Abstract

PURPOSE
The purposes of this study are to review the literature on quality of life intervention programs and to recommend further research and clinical considerations to improve the quality of life among patients with schizophrenia.
METHODS
Three electronic databases - PubMed, CHINAHL and RISS - were searched using the search terms of "schizophrenia" AND "quality of life" AND "intervention*" OR "program*." The search was limited to studies published in English and Korean.
RESULTS
Ten studies were selected for the final analysis and evaluated in terms of contextual and methodological quality. The 10 studies consisted of 5 randomized controlled trials, 4 quasi-experimental studies, and 1 case report. The selected studies utilized an educational program, art and music therapy, physical activity therapy, and community-based integrated programs to alleviate psychological symptoms and showed effectiveness in improving quality of life.
CONCLUSION
Interdisciplinary interventions and programs using multiple components reduced psychological symptoms and improved the quality of life of patients with schizophrenia.

Keyword

Schizophrenia; Quality of life; Literature review

MeSH Terms

Humans
Motor Activity
Music Therapy
Non-Randomized Controlled Trials as Topic
Quality of Life*
Schizophrenia*

Figure

• 

  Figure 1 Flow chart of study selection.

Reference

1. Goldstein JM, Cherkerzian S, Tsuang MT, Petryshen TL. Sex differences in the genetic risk for schizophrenia: history of the evidence for sex-specific and sex-dependent effects. Am J Med Genet B Neuropsychiatr Genet. 2013; 162:698–710. DOI: 10.1002/ajmg.b.32159.

2. Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, allcause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016; 388(10053):1459–1544. DOI: 10.1016/S0140-6736(16)31012-1.

3. Ministry of Health and Welfare. The epidemiological survey of mental disorders in Korea. Ministry of Health and Welfare Statistics [Internet]. 2016. cited 2017 Sep 16. Available from: http://www.mohw.go.kr/react/jb/sjb1101ls.jsp?PAR_MENU_ID=03&MENU_ID=03320101.

4. World Health Organization (WHO). The ICD-10 online version: 2016. International Classification of Diseases [Internet]. 2016. cited 2018 Feb 23. Available from: http://www.who.int/classifications/icd/icdonlineversions/en/.

5. Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016; 388(10039):86–97. DOI: 10.1016/S0140-6736(15)01121-6.

6. Park SA, Sung KM. Development of a measurement of stress for hospitalized schizophrenic patient. J Korean Acad Nurs. 2014; 44(3):339–349. DOI: 10.4040/jkan.2014.44.3.339.

7. Wunderink L, Nieboer RM, Wiersma D, Sytema S, Nienhuis FJ. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance strategy. JAMA Psychiatry. 2013; 70:913–920. DOI: 10.1001/jamapsychiatry.2013.19.

8. Ministry of Health and Welfare. Some amendments to the act on the promotion of mental health and support for welfare services for mentally ill patients. Bill Information [Internet]. 2017. cited 2017 Jun 14. Available from: http://likms.assembly.go.kr/bill/billDetail.do?billId=PRC_P1K6K.

9. Hsiao CY, Hsieh MH, Tseng CJ, Chien SH, Chan CC. Quality of life of individuals with schizophrenia living in the community: relationship to socio-demographic, clinical and psychosocial characteristics. J Clin Nurs. 2012; 21(15-16):2367–2376. DOI: 10.1111/j.1365-2702.2012.04067.x.

10. Yoo SY. Developing a prediction model for quality of life in patients with schizophrenia. J Korean Acad Psychiatr Ment Health Nurs. 2014; 23(3):144–155. DOI: 10.12934/jkpmhn.2014.23.3.144.

11. Galuppi A, Turola MC, Nanni MG, Mazzoni P, Grassi L. Schizophrenia and quality of life: how important are symptoms and functioning? Int J Ment Health Syst. 2010; 4(31):1–8. DOI: 10.1186/1752-4458-4-31.

12. Brissos S, Dias VV, Balanzá-Martinez V, Carita AI, Figueira ML. Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance. Schizophr Res. 2011; 129(2-3):133–136. DOI: 10.1016/j.schres.2011.04.001.

13. Górna K, Jaracz K, Jaracz J, Kiejda J, Grabowska-Fudala B, Rybakowski J. Social functioning and quality of life in schizophrenia patients-relationship with symptomatic remission and duration of illness. Psychiatr Pol. 2014; 48(2):277–288.

14. Priebe S, McCabe R, Junghan U, Kallert T, Ruggeri M, Slade M, et al. Association between symptoms and quality of life in patients with schizophrenia: a pooled analysis of changes over time. Schizophr Res. 2011; 133(1-3):17–21. DOI: 10.1016/j.schres.2011.09.021.

15. Madhivanan S, Jayaraman K, Daniel SJ, Ramasamy J. Symptomatic remission in schizophrenia and its relationship with functional outcome measures in Indian population. J Clin Diagn Res. 2017; 11(1):VC05–VC07. DOI: 10.7860/JCDR/2017/22320.9242.

16. Meesters PD, Comijs HC, de Haan L, Smit JH, Eikelenboom P, Beekman AT, et al. Subjective quality of life and its determinants in a catchment area based population of elderly schizophrenia patients. Schizophr Res. 2013; 147(2-3):275–280. DOI: 10.1016/j.schres.2013.04.030.

17. Pitkänen A, Välimäki M, Kuosmanen L, Katajisto J, Koivunen M, Hätönen H, et al. Patient education methods to support quality of life and functional ability among patients with schizophrenia: a randomized clinical trial. Qual Life Res. 2012; 21(2):247–256. DOI: 10.1007/s11136-011-9944-1.

18. Loh SY, Abdullah A, Abu Bakar AK, Thambu M, Nik Jaafar NR. Structured walking and chronic institutionalized schizophrenia inmates: a pilot RCT study on quality of life. Glob J Health Sci. 2015; 8(1):238–248. DOI: 10.5539/gjhs.v8n1p238.

19. Wang FZ, Luo D, Kan W, Wang Y. Combined intervention with education and progressive muscle relaxation on quality of life, functional disability, and positive symptoms in patients with acute schizophrenia. J Altern Complement Med. 2015; 21(3):159–165. DOI: 10.1089/acm.2014.0128.

20. Schlosser D, Campellone T, Kim D, Truong B, Vergani S, Ward C, et al. Feasibility of PRIME: a cognitive neuroscience-informed mobile app intervention to enhance motivated behavior and improve quality of life in recent onset schizophrenia. JMIR Res Protoc. 2016; 5(2):e77. DOI: 10.2196/resprot.5450.

21. Kang BI. The effect of group art therapy on emotional expression, emotional behavior, interpersonal relationship, and quality of life in inpatients with schizophrenia. Clin Arts Ther Stud. 2015; 4(1):27–51.

22. Lambert M, Bock T, Schöttle D, Golks D, Meister K, Rietschel L, et al. Assertive community treatment as part of integrated care versus standard care: a 12-month trial in patients with firstand multiple-episode schizophrenia spectrum disorders treated with Quetiapine immediate release (ACCESS Trial). J Clin Psychiatry. 2010; 71(10):1313–1323. DOI: 10.4088/JCP.09m05113yel.

23. Jeon GS, Gang M, Oh K. The effectiveness of the Nanta-program on psychiatric symptoms, interpersonal relationships, and quality of life in forensic inpatients with schizophrenia. Arch Psychiatr Nurs. 2017; 31(1):93–98. DOI: 10.1016/j.apnu.2016.09.005.

24. Ryu JM. The effects of group art therapy on the interpersonal relationship and the quality of life of chronic schizophrenic patients dwelling in the facilities. J Humanit Soc Sci 21. 2015; 6(4):213–231.

25. Choi HM. Effect of the group art therapy on stress coping strategy and quality of life in schizophrenia patients. Clin Arts Ther Stud. 2015; 4(1):131–150.

26. Kim KH, Kim TW. A case study of art therapy on the quality of life for chronic schizophrenic patient. Korean J Art Ther. 2017; 24(6):1531–1555.

27. Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005; 52(5):546–553. DOI: 10.1111/j.1365-2648.2005.03621.x.

28. Scottish Intercollegiate Guidelines Network (SIGN). Methodology check list 2: randomized controlled trials. SIGN [Internet]. 2013. cited 2013 May 9. Available from: http://www.sign.ac.uk/our-guidelines.html.

29. Enhancing the QUAlity and Transparency Of health Research (EQUATOR). Reporting guidelines for main study types. EQUATOR [Internet]. 2013. cited 2013 Sep 2. Available from: http://www.care-statement.org/downloads.

30. Marshall M, Lockwood A. WITHDRAWN: Assertive community treatment for people with severe mental disorders. Cochrane Database Syst Rev. 2011; 13(4):CD001089. DOI: 10.1002/14651858.CD001089.pub2.